Elms Steve
SEC-identified person · CIK 1250195 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| R&R Acquisition VI, INC ADMA | Director | filed 2012–2026 |
| Tapimmune INC. TPIV.OB | Director | filed 2019–2025 |
| Elevation Oncology, Inc. ELEV | Director | filed 2021–2025 |
| Zosano Pharma Corp ZSAN | Director | filed 2018–2021 |
| Viracta Therapeutics, Inc. VIRX | Officer | filed 2019–2019 |
| Loxo Oncology, Inc. LOXO | Director | filed 2014–2019 |
| Syros Pharmaceuticals, Inc. SYRS | Officer | filed 2016–2016 |
| Agile Therapeutics INC AGRX | Director | filed 2014–2016 |
| Pernix Therapeutics Holdings, INC. PTX | Director | filed 2012–2016 |
| Viewray, Inc. VRAY | Officer | filed 2016–2016 |
| Transenterix, INC. TRXC.OB | Officer | filed 2013–2016 |
| T2 Biosystems, Inc. TTOO | Director | filed 2014–2015 |
| Esperion Therapeutics, Inc. ESPR | Officer | filed 2013–2015 |
| Cidara Therapeutics, Inc. CDTX | Director | filed 2015–2015 |
| Versartis, Inc. VSAR | Officer | filed 2014–2015 |
| Ambit Biosciences Corp AMBI | Director | filed 2013–2014 |
| Durata Therapeutics, Inc. DRTX | Officer | filed 2012–2014 |
| Zeltiq Aesthetics Inc ZLTQ | Officer | filed 2011–2014 |
| Melinta Therapeutics, INC. /NEW/ MLNT | Officer | filed 2012–2012 |
| MAP Pharmaceuticals, Inc. MAPP | Director | filed 2007–2010 |
| Interpharm Holdings INC IPA | Officer | filed 2007–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.